About this trial
The study aims to compare the readings from two methods of monitoring carbon dioxide levels during jet ventilation when normal end-tidal monitoring is not possible. During jet ventilation it is technically not possible to monitor the levels of carbon dioxide in exhaled air as is the standard in preoperative care. We will compare transcutaneous (through the skin) monitoring to an arterial blood. sample. Both transcutaneous monitoring and arterial monitoring is currently used as the standard for this patient group at our institution. By collecting data prospectively we can evaluate if there. are discrepancies based on monitoring method. All patients will be treated per standard preoperative protocol and only patients consenting to participate will contribute data to the comparison and statistical analysis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adult patients undergoing percutaneous RF liver tumour ablation requiring jet ventilation
Disqualifiers
disease or condition. not compatible with jet ventilation
Trial population
Adults undergoing percutaneous RF liver ablation under jet ventilation
Trial design
Case-only
Prospective
Treatments tested in this trial
No Interventions
Other interventionNo intervention, solely data collection
Treatment groups
Trial outcomes
Primary outcomes
Difference in CO2 between TcCO2 and PaCO2
Sponsors and contacts
Click on the lead sponsor to view all of their trials.